Insider filing · KNSA
G Bradley Cole
Director
profile →
Kiniksa Pharmaceuticals International, plc
KNSA · Healthcare · 68 filings in 24 months
ticker →
G Bradley Cole sold $299K of Kiniksa Pharmaceuticals International (KNSA)
Executed Jul 29, disclosed Jul 31, 2 days later.
Value, as filed
$299K
3,673 sh × $81.43
Executed
Jul 29
the trade date, as filed
Disclosed
Jul 31
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GCG Bradley Cole (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $299K of KNSA (3,673 sh × $81.43, as filed), executed Jul 29.
The name
KNSAHealthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→